Breaking News

You are here » Indian-Commodity  :  Commodities  :  Gold, Silver & Bullion  :  Gold futures end almost flat on Thursday

10-Aug2018

Gold futures end almost flat on Thursday

Gold futures ended almost flat on Thursday with the current holding pattern, as the latest round of economic data on jobs and inflation did little to dissuade investors from buying assets perceived as risky over safe-heaven bullion. Meanwhile, stronger dollar capped the upside momentum.

Gold futures for December delivery settled down $1.10, or 0.1 percent, at $1,219.90 per ounce, on the Comex division of the New York Mercantile. While, spot gold was flat at $1,213.05 per ounce.



Related News

View all news

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Gold futures decline on firming dollar

Gold futures declined on MCX as traders await the minutes from the US Federal Reserve's latest policy meeting for fresh clues on the pace of interest rate hikes. Besides, a firming dollar against some......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......